

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.97317039 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.40555281 |
| 3 | negative regulation of cell killing (GO:0031342) | 6.40555281 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.92782546 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.92782546 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.92782546 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.92782546 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.92782546 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.92782546 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.72873171 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 5.66936062 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.51777564 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.35172531 |
| 14 | detection of other organism (GO:0098543) | 5.25590188 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.18643015 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.04424071 |
| 17 | detection of bacterium (GO:0016045) | 4.96410602 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.83600424 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 4.81991188 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.79674626 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.69773506 |
| 22 | neutrophil activation (GO:0042119) | 4.64488796 |
| 23 | leukocyte aggregation (GO:0070486) | 4.64353395 |
| 24 | response to peptidoglycan (GO:0032494) | 4.62100054 |
| 25 | cellular extravasation (GO:0045123) | 4.52004669 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.49565337 |
| 27 | response to interleukin-15 (GO:0070672) | 4.31888225 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.26842489 |
| 29 | respiratory burst (GO:0045730) | 4.24719774 |
| 30 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.18997228 |
| 31 | microglial cell activation (GO:0001774) | 4.12799800 |
| 32 | detection of biotic stimulus (GO:0009595) | 4.11177592 |
| 33 | granulocyte activation (GO:0036230) | 4.10285953 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 4.08165756 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.06575159 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.02481827 |
| 37 | response to host immune response (GO:0052572) | 4.02481827 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 4.01589744 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.99747244 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.98979035 |
| 41 | neutrophil mediated immunity (GO:0002446) | 3.91126673 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.84319583 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.75859310 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.74436092 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.74240492 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.73384365 |
| 47 | macrophage activation (GO:0042116) | 3.69259433 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.69149935 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.66818211 |
| 50 | response to host (GO:0075136) | 3.64948587 |
| 51 | response to host defenses (GO:0052200) | 3.64948587 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.64948587 |
| 53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.63847523 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 3.55932586 |
| 55 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.49435344 |
| 56 | regulation of leukocyte degranulation (GO:0043300) | 3.48315309 |
| 57 | leukocyte degranulation (GO:0043299) | 3.45885041 |
| 58 | positive regulation of mast cell activation (GO:0033005) | 3.45685695 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.42720902 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.36590986 |
| 61 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.34491681 |
| 62 | myeloid leukocyte mediated immunity (GO:0002444) | 3.33308000 |
| 63 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29304811 |
| 64 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29256575 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.25756810 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.24813522 |
| 67 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.20764078 |
| 68 | cellular response to type I interferon (GO:0071357) | 3.19410068 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.19410068 |
| 70 | response to type I interferon (GO:0034340) | 3.18710631 |
| 71 | dendritic cell chemotaxis (GO:0002407) | 3.10403613 |
| 72 | dendritic cell migration (GO:0036336) | 3.09225762 |
| 73 | regulation of regulated secretory pathway (GO:1903305) | 3.08942097 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08866789 |
| 75 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08866789 |
| 76 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.07504951 |
| 77 | regulation of tolerance induction (GO:0002643) | 3.06453276 |
| 78 | regulation of B cell differentiation (GO:0045577) | 3.04601510 |
| 79 | germinal center formation (GO:0002467) | 3.02721005 |
| 80 | B cell mediated immunity (GO:0019724) | 2.98605034 |
| 81 | neutrophil chemotaxis (GO:0030593) | 2.98454904 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 2.98090504 |
| 83 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97120626 |
| 84 | neutrophil migration (GO:1990266) | 2.90757116 |
| 85 | defense response to protozoan (GO:0042832) | 2.89179051 |
| 86 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88115583 |
| 87 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88115583 |
| 88 | negative regulation of interleukin-6 production (GO:0032715) | 2.87958666 |
| 89 | relaxation of smooth muscle (GO:0044557) | 2.84524763 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83918647 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 2.83918647 |
| 92 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 2.83503997 |
| 93 | myeloid leukocyte activation (GO:0002274) | 2.80963875 |
| 94 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77997023 |
| 95 | regulation of platelet aggregation (GO:0090330) | 2.77952161 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 2.77491328 |
| 97 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.76818973 |
| 98 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.76668129 |
| 99 | regulation of regulatory T cell differentiation (GO:0045589) | 2.75349393 |
| 100 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.74759872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.80808376 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.74995505 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.34402214 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33081047 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.14114187 |
| 6 | SPI1_23127762_ChIP-Seq_K562_Human | 2.80885009 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72523155 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71737182 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65937873 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64552888 |
| 11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.57792618 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54183910 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46387315 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46108077 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45823135 |
| 16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34780798 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27863310 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.26152258 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24091320 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22721841 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14646149 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14042831 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.10993752 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08575219 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04604476 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03401983 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.99748816 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.99172445 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.91420795 |
| 30 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.89488699 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88740803 |
| 32 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.85130509 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78599269 |
| 34 | MAF_26560356_Chip-Seq_TH2_Human | 1.77478956 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70950442 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70299474 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68299382 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67491434 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66934536 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66297360 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66055921 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65420618 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64267284 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62250073 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48227788 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48124709 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47985712 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42664630 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42647826 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41555168 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40919669 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40284138 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40127409 |
| 54 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36739817 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36549742 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35195830 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.34574904 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33023361 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31349553 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30128762 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29935101 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28184835 |
| 63 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24726110 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23663337 |
| 65 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.21018802 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20870083 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20686948 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18302275 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17741677 |
| 70 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.16397521 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15377726 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14543338 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14462145 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13723220 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13531724 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12792629 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12749429 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09572009 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08827905 |
| 80 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03631570 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02940769 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99903141 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98742733 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97794071 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96615146 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92643407 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91603161 |
| 88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.90252583 |
| 89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88776154 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87234665 |
| 91 | * P300_27268052_Chip-Seq_Bcells_Human | 0.85307171 |
| 92 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85045590 |
| 93 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84884879 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.81887613 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81613710 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81518219 |
| 97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80504357 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79209700 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.78987137 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78898997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.84983810 |
| 2 | MP0003436_decreased_susceptibility_to | 4.19882438 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.56490770 |
| 4 | MP0003303_peritoneal_inflammation | 3.54711768 |
| 5 | MP0002419_abnormal_innate_immunity | 3.12501939 |
| 6 | MP0008004_abnormal_stomach_pH | 3.05700418 |
| 7 | MP0002132_abnormal_respiratory_system | 3.03039779 |
| 8 | MP0009785_altered_susceptibility_to | 2.87487634 |
| 9 | MP0005025_abnormal_response_to | 2.83464711 |
| 10 | MP0001800_abnormal_humoral_immune | 2.72618080 |
| 11 | MP0005671_abnormal_response_to | 2.68293405 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.62842466 |
| 13 | MP0005410_abnormal_fertilization | 2.59260738 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.57014425 |
| 15 | MP0000685_abnormal_immune_system | 2.56878765 |
| 16 | MP0005387_immune_system_phenotype | 2.50620394 |
| 17 | MP0001790_abnormal_immune_system | 2.50620394 |
| 18 | MP0002723_abnormal_immune_serum | 2.49968406 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.49009739 |
| 20 | MP0001819_abnormal_immune_cell | 2.45895074 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.38456727 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.32934241 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.14921504 |
| 24 | MP0006082_CNS_inflammation | 2.10296734 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.09566407 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.08680208 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.03974475 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.95905694 |
| 29 | MP0003828_pulmonary_edema | 1.94110469 |
| 30 | MP0002405_respiratory_system_inflammati | 1.91556282 |
| 31 | MP0002398_abnormal_bone_marrow | 1.89291029 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.86937646 |
| 33 | MP0000716_abnormal_immune_system | 1.81920415 |
| 34 | MP0008260_abnormal_autophagy | 1.77979814 |
| 35 | MP0004381_abnormal_hair_follicle | 1.76164269 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.73904437 |
| 37 | MP0009278_abnormal_bone_marrow | 1.69150264 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.67448980 |
| 39 | MP0003866_abnormal_defecation | 1.60094320 |
| 40 | MP0003045_fibrosis | 1.56095382 |
| 41 | MP0002722_abnormal_immune_system | 1.52084908 |
| 42 | MP0005451_abnormal_body_composition | 1.48917927 |
| 43 | MP0004883_abnormal_blood_vessel | 1.47441538 |
| 44 | MP0009764_decreased_sensitivity_to | 1.46321805 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.45340161 |
| 46 | MP0002429_abnormal_blood_cell | 1.43551124 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.41452813 |
| 48 | MP0004947_skin_inflammation | 1.41213512 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.39795389 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.38698360 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.35274847 |
| 52 | MP0008469_abnormal_protein_level | 1.30854127 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.29137016 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.29137016 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.28595893 |
| 56 | MP0000343_altered_response_to | 1.24812931 |
| 57 | MP0003075_altered_response_to | 1.24148121 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.22447853 |
| 59 | MP0000858_altered_metastatic_potential | 1.18223824 |
| 60 | MP0005164_abnormal_response_to | 1.18222457 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.17267309 |
| 62 | MP0001851_eye_inflammation | 1.15986688 |
| 63 | MP0004510_myositis | 1.11993129 |
| 64 | MP0005166_decreased_susceptibility_to | 1.09516882 |
| 65 | MP0005310_abnormal_salivary_gland | 0.95763337 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.95198212 |
| 67 | MP0003315_abnormal_perineum_morphology | 0.93676504 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 0.93389766 |
| 69 | MP0003878_abnormal_ear_physiology | 0.93389766 |
| 70 | MP0005248_abnormal_Harderian_gland | 0.86257214 |
| 71 | MP0000490_abnormal_crypts_of | 0.79954230 |
| 72 | MP0005390_skeleton_phenotype | 0.79268606 |
| 73 | MP0000015_abnormal_ear_pigmentation | 0.77088401 |
| 74 | MP0009763_increased_sensitivity_to | 0.74288796 |
| 75 | MP0001663_abnormal_digestive_system | 0.74048038 |
| 76 | MP0003690_abnormal_glial_cell | 0.73166967 |
| 77 | MP0003795_abnormal_bone_structure | 0.71843905 |
| 78 | MP0008874_decreased_physiological_sensi | 0.71095636 |
| 79 | MP0005083_abnormal_biliary_tract | 0.66803752 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.65918723 |
| 81 | MP0003448_altered_tumor_morphology | 0.65532393 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.63230038 |
| 83 | MP0004484_altered_response_of | 0.60777556 |
| 84 | MP0000249_abnormal_blood_vessel | 0.59920683 |
| 85 | MP0000470_abnormal_stomach_morphology | 0.58912028 |
| 86 | MP0003698_abnormal_male_reproductive | 0.58590056 |
| 87 | MP0004130_abnormal_muscle_cell | 0.57958347 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.56112301 |
| 89 | MP0005388_respiratory_system_phenotype | 0.55969433 |
| 90 | MP0002133_abnormal_respiratory_system | 0.55969433 |
| 91 | MP0001664_abnormal_digestion | 0.55422496 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.55415332 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.54682212 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.54575780 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.50888608 |
| 96 | MP0001849_ear_inflammation | 0.49166416 |
| 97 | MP0002653_abnormal_ependyma_morphology | 0.47578793 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.47319912 |
| 99 | MP0001929_abnormal_gametogenesis | 0.47259632 |
| 100 | MP0005647_abnormal_sex_gland | 0.46944982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.74142646 |
| 2 | Myositis (HP:0100614) | 6.00256981 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.87911782 |
| 4 | Orchitis (HP:0100796) | 5.81431539 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.63991315 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.50035927 |
| 7 | Optic neuritis (HP:0100653) | 5.50035927 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.25197719 |
| 9 | Stomatitis (HP:0010280) | 5.04647292 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.94555857 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.47751683 |
| 12 | Obstructive lung disease (HP:0006536) | 4.47751683 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.42065082 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.38142932 |
| 15 | Prolonged bleeding time (HP:0003010) | 4.37931360 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 4.13125814 |
| 17 | Keratoconjunctivitis sicca (HP:0001097) | 4.03990770 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.94794474 |
| 19 | Meningitis (HP:0001287) | 3.93421371 |
| 20 | Spontaneous hematomas (HP:0007420) | 3.87359031 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.84427280 |
| 22 | Encephalitis (HP:0002383) | 3.79841372 |
| 23 | Keratoconjunctivitis (HP:0001096) | 3.73472471 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.62595490 |
| 25 | Recurrent skin infections (HP:0001581) | 3.60113530 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.55389090 |
| 27 | Gingivitis (HP:0000230) | 3.50356584 |
| 28 | Increased IgE level (HP:0003212) | 3.44230300 |
| 29 | Urticaria (HP:0001025) | 3.42911970 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 3.40239401 |
| 31 | Vasculitis (HP:0002633) | 3.38604884 |
| 32 | Hypochromic anemia (HP:0001931) | 3.37255979 |
| 33 | Gingival bleeding (HP:0000225) | 3.26239268 |
| 34 | Epistaxis (HP:0000421) | 3.24346971 |
| 35 | Colitis (HP:0002583) | 3.21139835 |
| 36 | Episodic fever (HP:0001954) | 3.15468167 |
| 37 | Petechiae (HP:0000967) | 3.15348424 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14547549 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14547549 |
| 40 | Chest pain (HP:0100749) | 3.11613012 |
| 41 | Cellulitis (HP:0100658) | 3.06277092 |
| 42 | Resting tremor (HP:0002322) | 3.03411611 |
| 43 | Arterial thrombosis (HP:0004420) | 3.02080145 |
| 44 | Peritonitis (HP:0002586) | 2.99109720 |
| 45 | Hemoptysis (HP:0002105) | 2.87739978 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.85142488 |
| 47 | Abnormal platelet volume (HP:0011876) | 2.81752792 |
| 48 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.79923712 |
| 49 | Pulmonary embolism (HP:0002204) | 2.79567587 |
| 50 | Anorexia (HP:0002039) | 2.74608312 |
| 51 | Leukocytosis (HP:0001974) | 2.71576015 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.68382991 |
| 53 | Purpura (HP:0000979) | 2.65679963 |
| 54 | Nasal polyposis (HP:0100582) | 2.65586974 |
| 55 | T lymphocytopenia (HP:0005403) | 2.65332456 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.56941974 |
| 57 | Microcytic anemia (HP:0001935) | 2.55638031 |
| 58 | Granulocytopenia (HP:0001913) | 2.50459889 |
| 59 | Osteomyelitis (HP:0002754) | 2.46387111 |
| 60 | Increased IgM level (HP:0003496) | 2.43752765 |
| 61 | Abnormality of T cells (HP:0002843) | 2.34704074 |
| 62 | Menorrhagia (HP:0000132) | 2.34119880 |
| 63 | Postural instability (HP:0002172) | 2.33475769 |
| 64 | Gangrene (HP:0100758) | 2.32509522 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 2.32326013 |
| 66 | Amyloidosis (HP:0011034) | 2.32077257 |
| 67 | Abnormality of the columella (HP:0009929) | 2.28365858 |
| 68 | Polyneuropathy (HP:0001271) | 2.27900314 |
| 69 | Sepsis (HP:0100806) | 2.26676863 |
| 70 | Pustule (HP:0200039) | 2.22667814 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.21175128 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.19869362 |
| 73 | Recurrent viral infections (HP:0004429) | 2.19716500 |
| 74 | Abnormal sex determination (HP:0012244) | 2.18840105 |
| 75 | Sex reversal (HP:0012245) | 2.18840105 |
| 76 | Eosinophilia (HP:0001880) | 2.15634585 |
| 77 | Glomerulopathy (HP:0100820) | 2.13457862 |
| 78 | Acute hepatic failure (HP:0006554) | 2.10780208 |
| 79 | Abnormality of the endocardium (HP:0004306) | 2.07776649 |
| 80 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.07528516 |
| 81 | Vertigo (HP:0002321) | 2.06427270 |
| 82 | Hepatosplenomegaly (HP:0001433) | 2.06241527 |
| 83 | Chronic otitis media (HP:0000389) | 2.05897884 |
| 84 | Lymphopenia (HP:0001888) | 2.03784540 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.02368108 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 2.01898086 |
| 87 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.01898086 |
| 88 | Keratitis (HP:0000491) | 2.01869670 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 2.01099034 |
| 90 | Difficulty running (HP:0009046) | 1.98174985 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 1.97449672 |
| 92 | Recurrent pneumonia (HP:0006532) | 1.93828784 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 1.93398474 |
| 94 | Recurrent sinusitis (HP:0011108) | 1.93211519 |
| 95 | Skin ulcer (HP:0200042) | 1.93078827 |
| 96 | Acne (HP:0001061) | 1.92638226 |
| 97 | Increased mean platelet volume (HP:0011877) | 1.90565259 |
| 98 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.90093023 |
| 99 | Abnormality of the pericardium (HP:0001697) | 1.83089346 |
| 100 | Premature loss of primary teeth (HP:0006323) | 1.77668667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.82525675 |
| 2 | PINK1 | 4.29524987 |
| 3 | MARK3 | 3.40225210 |
| 4 | IRAK4 | 3.23156734 |
| 5 | MAP4K1 | 3.09827076 |
| 6 | BLK | 2.83063187 |
| 7 | MAP2K3 | 2.80951082 |
| 8 | FES | 2.63161007 |
| 9 | GRK6 | 2.60056171 |
| 10 | CSK | 2.58722048 |
| 11 | ERN1 | 2.46151634 |
| 12 | TNK2 | 2.37881429 |
| 13 | EPHB1 | 2.34524031 |
| 14 | TYK2 | 2.24476476 |
| 15 | TAOK1 | 2.01150539 |
| 16 | BTK | 1.98071034 |
| 17 | FGR | 1.97380734 |
| 18 | ZAP70 | 1.90034077 |
| 19 | HCK | 1.86050837 |
| 20 | MAP3K3 | 1.81878239 |
| 21 | MAP3K1 | 1.53235244 |
| 22 | SYK | 1.52228736 |
| 23 | KSR2 | 1.49164588 |
| 24 | MAP3K11 | 1.48693991 |
| 25 | JAK2 | 1.43428550 |
| 26 | TXK | 1.42788965 |
| 27 | JAK3 | 1.40992242 |
| 28 | LYN | 1.30256745 |
| 29 | PRPF4B | 1.27446672 |
| 30 | STK38 | 1.23568489 |
| 31 | MAP3K13 | 1.13720492 |
| 32 | YES1 | 1.11024972 |
| 33 | IKBKE | 1.04976094 |
| 34 | PTK2B | 1.04199025 |
| 35 | TLK1 | 1.04069825 |
| 36 | TAOK3 | 1.01948142 |
| 37 | SIK3 | 0.99194384 |
| 38 | IRAK2 | 0.96682603 |
| 39 | CSF1R | 0.95860621 |
| 40 | PDK1 | 0.95125321 |
| 41 | LCK | 0.94706258 |
| 42 | MARK2 | 0.94603719 |
| 43 | KIT | 0.92992577 |
| 44 | JAK1 | 0.92180657 |
| 45 | PDPK1 | 0.90805206 |
| 46 | PTK6 | 0.87901188 |
| 47 | TBK1 | 0.87697757 |
| 48 | MAP3K14 | 0.87364599 |
| 49 | IRAK1 | 0.84959491 |
| 50 | ITK | 0.83282965 |
| 51 | MYLK | 0.81759542 |
| 52 | PRKCQ | 0.81447667 |
| 53 | MAP3K5 | 0.81194059 |
| 54 | DYRK3 | 0.77941053 |
| 55 | RPS6KA5 | 0.77672677 |
| 56 | TEC | 0.76183166 |
| 57 | MAP3K2 | 0.75722406 |
| 58 | MATK | 0.72004198 |
| 59 | PRKD2 | 0.71163873 |
| 60 | TESK2 | 0.69302453 |
| 61 | CDK19 | 0.69021864 |
| 62 | TAOK2 | 0.67817400 |
| 63 | SIK2 | 0.67787573 |
| 64 | RET | 0.67524819 |
| 65 | CDC42BPA | 0.64478205 |
| 66 | MAPK12 | 0.64205726 |
| 67 | TRIB3 | 0.63500470 |
| 68 | RAF1 | 0.62159956 |
| 69 | LRRK2 | 0.60634861 |
| 70 | MAP3K6 | 0.60564742 |
| 71 | PIK3CG | 0.59808545 |
| 72 | PRKG2 | 0.59530702 |
| 73 | DYRK1B | 0.58658773 |
| 74 | FYN | 0.58501168 |
| 75 | MAP2K4 | 0.55247736 |
| 76 | STK11 | 0.53123662 |
| 77 | BMPR2 | 0.51994552 |
| 78 | STK10 | 0.50814306 |
| 79 | IKBKB | 0.50782887 |
| 80 | SGK3 | 0.49415846 |
| 81 | SGK223 | 0.46025852 |
| 82 | SGK494 | 0.46025852 |
| 83 | MAP3K7 | 0.42990011 |
| 84 | EPHA3 | 0.42446024 |
| 85 | NLK | 0.40965832 |
| 86 | SMG1 | 0.40368164 |
| 87 | FGFR3 | 0.40054161 |
| 88 | SGK2 | 0.39461135 |
| 89 | PIM1 | 0.38485707 |
| 90 | TGFBR2 | 0.37593133 |
| 91 | KSR1 | 0.36385139 |
| 92 | DAPK2 | 0.35233083 |
| 93 | MAP2K6 | 0.32980044 |
| 94 | MAPKAPK2 | 0.32264507 |
| 95 | HIPK2 | 0.31995698 |
| 96 | RPS6KC1 | 0.31073562 |
| 97 | RPS6KL1 | 0.31073562 |
| 98 | PAK1 | 0.29331848 |
| 99 | PRKCZ | 0.28355044 |
| 100 | PKN2 | 0.27595355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.03558315 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.93672150 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75108576 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61959623 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.45706619 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30534178 |
| 7 | Phagosome_Homo sapiens_hsa04145 | 2.26428476 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.09818549 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.06492967 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02146373 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.94049025 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.90975787 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85651562 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.82449906 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80150590 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.77057519 |
| 17 | Apoptosis_Homo sapiens_hsa04210 | 1.73774715 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.67517177 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.65724577 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63475169 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62473153 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.60846811 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57756946 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51851307 |
| 25 | Platelet activation_Homo sapiens_hsa04611 | 1.49158462 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.49013049 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.47711536 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38963304 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.34408722 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33110465 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32175283 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31236416 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25660704 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25444679 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24804946 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24629301 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24253471 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21567310 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19086786 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07900580 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07539012 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04263801 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01199404 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.00022240 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96904182 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96809742 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95747868 |
| 48 | Endocytosis_Homo sapiens_hsa04144 | 0.95324551 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.88765897 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88023476 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.87444073 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87019654 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85350298 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.85165824 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83665914 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83267759 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82119724 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80051984 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77655570 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75527843 |
| 61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74708791 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73840452 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73599826 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.73251152 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71597974 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71532801 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70348568 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67696031 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67681523 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66632512 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65590254 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65231205 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64805813 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63811064 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62539668 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62278116 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61936996 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60026187 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55582085 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.53790740 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51319756 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50969035 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50374684 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49720968 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48459530 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.48453293 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.47985541 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47059040 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45833150 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45665379 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44608091 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42553560 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.42508436 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.41679362 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40957326 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39570135 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39552827 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39004946 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38949297 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38440516 |

